Latest Articles
-
What’s Next For Copart Stock?
The stock price of Copart (NASDAQ: CPRT), an online auto auction company, was up 10% on Friday, November 22. This can be attributed to the company’s upbeat quarterly results. Copart reported sales of $1.15 billion and earnings of $0.37 per...
-
Should You Pick Atkore Stock At $90?
The stock price of Atkore (NYSE: ATKR), an electrical safety products’ manufacturer, rose 5% on Friday, November 22. The company reported mixed results for the fourth quarter on November 21 while its outlook for fiscal 2025 was dismal. Thi...
-
Tesla & Trump: Risks To Consider
Tesla (NASDAQ:TSLA) stock has rallied by over 45% since November 5th, the presidential election day, with its market cap now standing at over $1.1 trillion. Musk played a pivotal role in Trump’s 2024 campaign. Besides making considerable fi...
-
Can Streaming Gains Drive Disney Stock 2x?
Disney (NYSE:DIS) Q4 results show that its streaming business is finally hitting its stride. While the company’s theme parks and cable TV faced pressure, the streaming business performed well. Over the last quarter, the direct-to-consumer s...
-
What’s Next For Gap Stock?
Note : Gap’s FY’23 ended on February 3, 2024. After a 24% rise year-to-date (YTD), at the current price of around $22 per share, we believe Gap Inc. stock (NYSE: GPS), a specialty retailer selling casual apparel, accessories, and p...
-
What’s Driving Altria Stock Higher?
The stock price of Altria (NYSE: MO) has risen around 15% in a month, primarily due to a better than anticipated quarterly performance driven by growth in its oral tobacco products. Looking at a slightly longer period, Altria has seen its stock...
-
What’s Next For HIMS Stock?
The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of Eli Lilly’s weight loss drug – Zepboun...
-
Buy, Sell, Or Hold Deere Stock?
The stock price of Deere (NYSE: DE) surged 8% on November 21, after the company reported upbeat fiscal Q4 results (fiscal ends in October). It reported equipment revenue of $9.3 billion and earnings of $4.55 per share, compared to the street e...
-
Is The Worst Over For Super Micro Stock?
Super Micro Computer stock (NASDAQ: SMCI) gained about 15% in Thursday’s trading and remains up by close to 66% over the past week. The gains come as the company appears to have bought itself more time from being delisted from the Nasdaq ex...
-
Pick Honeywell Over 3M Stock?
Given its better valuation and prospects, we believe Honeywell stock (NYSE: HON) is currently a better pick than its sector peer, 3M stock (NYSE: MMM). HON stock trades at 22x forward expected earnings, versus 18x for MMM, and we think that t...
-
What’s Happening With ZETA Stock?
The stock price of Zeta Global Holdings (NYSE: ZETA), an AI-based marketing cloud platform, has risen a solid 20% in a week. Much of this move came after the company’s top executives announced their intention to buy $3 million worth of the...
-
What’s Next For Google Stock
Alphabet stock (NASDAQ: GOOG) has been in the news lately, with the Department of Justice suggesting the sale of Google Chrome, and sharing data with rivals, among other measures to end its monopoly. The judge has set the trial on proposals for...
-
Why Williams-Sonoma Stock Surged 27%
Williams-Sonoma (NYSE:WSM) stock gained about 27% in Wednesday’s trading following the company’s Q3 earnings report – taking its total gains so far this year to 76%. The company, which is known for its premium kitchenware and ho...
-
Lowe’s Stock Is Falling Despite Upbeat Q3
Lowe’s (NYSE: LOW), a home-improvement retailer, fell 4.6% on Tuesday, 19th November (to $259), as compared to a 0.4% growth in the S&P 500 index. In comparison, LOW’s peer Home Depot stock (NYSE: HD) saw its stock down 0.9% ...
-
Which Is A Better Pick: JNJ Stock Or ABBV Stock?
Given its better prospects, we believe that AbbVie stock (NYSE: ABBV) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ). Both AbbVie and J&J trade at 15x forward expected earnings. However, we think th...
